The goal of this observational study is to evaluaty the accuracy of current risk stratification of patients with endometrial cancer and to redefine lymph node staging recommendations based on real-world clinical data. The main question it aims to answer is:
Is there any group of patients who doesn't need lymph node staging for proper indication of adjuvant treatment? Participants are note taking any intervention. They are treated according to current standard of care and followed 3-years after primary surgery.
Women ≥18 years with newly diagnosed endometrial cancer (any histology)
Undergoing primary surgical management
Preoperative expert ultrasound, CT scan (could be waived in low risk cases)
Preoperatively early-stage (stage I-II) of EC
Neoadjuvant treatment
Recurrent or metastatic disease at diagnosis
Inadequate imaging or tissue samples
Cancer synchronous duplicity
Patients with histologicaly confirmed endometrial cancer.
Cohort
Prospective
No Intervention: Observational Cohort
Other interventionNo intervention
The accuracy of preoperative risk stratification
Determination of specific groups for whom: 1) lymph node staging is crucial for changing risk category and adjuvant treatment decisions, and 2) lymph node staging could be safely omitted
Click on the lead sponsor to view all of their trials.
